Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams (NCT07164131)

🧪 Interventions in This Study

• Doxycycline (DRUG)
• Azithromycin (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (5 Sites)

• Mayo Clinic in Arizona — Scottsdale, Arizona
• Mayo Clinic in Florida — Jacksonville, Florida
• Mayo Clinic Health System-Mankato — Mankato, Minnesota
• Mayo Clinic in Rochester — Rochester, Minnesota
• Mayo Clinic Health System-La Crosse — La Crosse, Wisconsin

📞 Contact the Study Coordinator

Phone: (800) 664-4580

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Community-acquired Pneumonia

• AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia — Chicago, Illinois
• Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP) — Mobile, Alabama
• Twice Daily Treatment With Amoxicillin for Non-severe Community Acquired Pneumonia. — Montreal, Quebec
• Optimizing Care for Children Hospitalized With Community-acquired Pneumonia: Novel Diagnostics — Hamilton, Ontario

Explore by condition: All Community-acquired Pneumonia clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.